Associate Professor Ilona Cunningham
People_

Associate Professor Ilona Cunningham

Clinical Associate Professor
Medicine: Concord Clinical School

Publications

Journals

  • Yeung, D., Cunningham, I., Ross, D., D'Souza, A., Wright, M., Harrup, R., Forsyth, C., Filshie, R., Lane, S., Browett, P., et al (2024). Asciminib monotherapy as frontline treatment of chronic phase chronic myeloid leukemia: results from the ASCEND study. Blood. [More Information]
  • Bleasel, J., Hopp, J., Cunningham, I., Ritchie, A. (2022). First case report of pre-mortem biopsy-proven kidney involvement by necrobiotic xanthogranuloma with monoclonal gammopathy. Journal of Nephrology, 35(6), 1753-1757. [More Information]
  • Fromm, P., Silveira, P., Hsu, J., Papadimitrious, M., Lo, T., Ju, X., Kupresanin, F., Romano, A., Hsu, W., Bryant, C., Kong, B., Abadir, E., McGuire, H., Fazekas de St Groth, B., Hart, D., Clark, G., et al (2020). Distinguishing human peripheral blood CD16+ myeloid cells based on phenotypic characteristics. Journal of Leukocyte Biology, 107(2), 323-339. [More Information]

2024

  • Yeung, D., Cunningham, I., Ross, D., D'Souza, A., Wright, M., Harrup, R., Forsyth, C., Filshie, R., Lane, S., Browett, P., et al (2024). Asciminib monotherapy as frontline treatment of chronic phase chronic myeloid leukemia: results from the ASCEND study. Blood. [More Information]

2022

  • Bleasel, J., Hopp, J., Cunningham, I., Ritchie, A. (2022). First case report of pre-mortem biopsy-proven kidney involvement by necrobiotic xanthogranuloma with monoclonal gammopathy. Journal of Nephrology, 35(6), 1753-1757. [More Information]

2020

  • Fromm, P., Silveira, P., Hsu, J., Papadimitrious, M., Lo, T., Ju, X., Kupresanin, F., Romano, A., Hsu, W., Bryant, C., Kong, B., Abadir, E., McGuire, H., Fazekas de St Groth, B., Hart, D., Clark, G., et al (2020). Distinguishing human peripheral blood CD16+ myeloid cells based on phenotypic characteristics. Journal of Leukocyte Biology, 107(2), 323-339. [More Information]

2019

  • Kenealy, M., Hertzberg, M., Benson, W., Taylor, K., Cunningham, I., Stevenson, W., Hiwase, D., Eek, R., Zantomio, D., Jong, S., et al (2019). Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia. Haematologica, 104(4), 700-709. [More Information]
  • Tan, S., Turner, J., Kerin-Ayres, K., Butler, S., Deguchi, C., Khatri, S., Mo, C., Warby, A., Cunningham, I., Malalasekera, M., Dhillon, H., Vardy, J. (2019). Health concerns of cancer survivors after primary anti-cancer treatment. Supportive Care in Cancer, 27(10), 3739-3747. [More Information]

2018

  • Thillainadesan, J., Ng, L., Cunningham, I., Wong Doo, N., Naganathan, V. (2018). Characteristics of older people in an inpatient haematology unit: A descriptive study. Australasian Journal on Ageing, 37(4), 293-299. [More Information]

2017

  • Trotman, J., Trinh, J., Kwan, Y., Estell, J., Fletcher, J., Archer, K., Lee, K., Foo, K., Curnow, J., Bianchi, A., Gasiorowski, R., Cunningham, I., et al (2017). Formalising multidisciplinary peer review: developing a haematological malignancy-specific electronic proforma and standard operating procedure to facilitate procedural efficiency and evidence-based clinical practice. Internal Medicine Journal, 47(5), 542-548. [More Information]